Institutional investors purchased a net $477.1 thousand shares of NVS during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 8.72% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LAZARD ASSET MANAGEMENT LLC Bought 3.2 Million shares of Novartis
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.8 Million shares of Novartis
ARISTOTLE CAPITAL MANAGEMENT LLC Bought 1.6 Million shares of Novartis